Bone Diseases Clinical Trials

A listing of Bone Diseases medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35235

A Phase 3 clinical study for patients with Degenerative Disc Disease

Arizona

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Degenerative Disc Disease

Tucson Arizona 85704

A clinical research study of Denosumab and Zoledronic acid

Arkansas

Fayetteville Arkansas 72703

A clinical research study of Denosumab and Zoledronic acid

California

Anaheim California 92801

A clinical research study of Denosumab and Zoledronic acid

Encinitas California 92024

A clinical research study of Denosumab and Zoledronic acid

Fresno California 93720

A clinical research study of Denosumab and Zoledronic acid

Pasadena California 91105

A Phase 3 clinical study for patients with Degenerative Disc Disease

Redwood City California 94063

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

View More ▼

Sacramento California 95816

A Phase 3 clinical study for patients with Degenerative Disc Disease

Santa Barbara California 93105

A clinical research study of Denosumab and Zoledronic acid

Santa Monica California 90403

A Phase 3 clinical study for patients with Degenerative Disc Disease

Walnut Creek California 94598

A Phase 3 clinical study for patients with Degenerative Disc Disease

Colorado

The Urology Center of Colorado
Denver Colorado 80211

Osteonecrosis of the Jaw (ONJ) Case Registry

View More ▼

Greenwood Village Colorado 80111

A Phase 3 clinical study for patients with Degenerative Disc Disease

Connecticut

Stamford Connecticut 06902

A clinical research study of Denosumab and Zoledronic acid

District of Columbia

Washington District of Columbia 20010

A clinical research study of Denosumab and Zoledronic acid

Washington District of Columbia 20037

A Phase 3 clinical study for patients with Degenerative Disc Disease

Florida

Arthritis and Rheumatic Disease Specialities
Aventura Florida 33180

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Center for Arthritis and Rheumatic Diseases
Miami Florida 33173

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Arthritis Center
Palm Harbor Florida 34684

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Sarasota Arthritis Research Center
Sarasota Florida 34239

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Florida Medical Clinic PA
Zephyrhills Florida 33542

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Boynton Beach Florida 33426

A clinical research study of Denosumab and Zoledronic acid

Fort Lauderdale Florida 33314 and 33133

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Jacksonville Florida 32256

A clinical research study of Denosumab and Zoledronic acid

Oakland Park Florida 33334

A Phase 3 clinical study for patients with Degenerative Disc Disease

Georgia

Atlanta Georgia 30329

A Phase 3 clinical study for patients with Degenerative Disc Disease

Atlanta Georgia 30329

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Savannah Georgia 31405

A clinical research study of Denosumab and Zoledronic acid

Illinois

Deerbrook Medical Associates
Vernon Hills Illinois 60061

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Bloomington Illinois 61701

A Phase 3 clinical study for patients with Degenerative Disc Disease

Joliet Illinois 60435

A clinical research study of Denosumab and Zoledronic acid

Maywood Illinois 60153

A clinical research study of Denosumab and Zoledronic acid

Skokie Illinois 60076

A clinical research study of Denosumab and Zoledronic acid

Skokie Illinois 60077

A clinical research study of Denosumab and Zoledronic acid

Indiana

Dawes-Fretzin Clinical Research
Indianapolis Indiana 46256

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Anderson Indiana 46016

A clinical research study of Denosumab and Zoledronic acid

Fort Wayne Indiana 46845

A clinical research study of Denosumab and Zoledronic acid

Indianapolis Indiana 46202

A clinical research study of Denosumab and Zoledronic acid

Iowa

Ames Iowa 50010

A clinical research study of Denosumab and Zoledronic acid

Iowa City Iowa 52242

A clinical research study of Denosumab and Zoledronic acid

Kentucky

Graves Gilbert Clinic
Bowling Green Kentucky 42101

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Edgewood Kentucky 41017

A Phase 3 clinical study for patients with Degenerative Disc Disease

Paducah Kentucky 42003

A clinical research study of Denosumab and Zoledronic acid

Louisiana

Shreveport Louisiana 71103

A Phase 3 clinical study for patients with Degenerative Disc Disease

Maine

Scarborough Maine 04074

A clinical research study of Denosumab and Zoledronic acid

Maryland

Baltimore Maryland 21237

A clinical research study of Denosumab and Zoledronic acid

Baltimore Maryland 21229

A clinical research study of Denosumab and Zoledronic acid

Baltimore Maryland 21204

A clinical research study of Denosumab and Zoledronic acid